Objective

• To significantly expand awareness of a biotech company among members of the institutional investment community; to generate interest in the company’s IPO and subsequent follow-on offering

Program

Pre-IPO

• Reviewed IPO roadshow investor targets provided by banking syndicate
• Developed list of high quality target healthcare investors to supplement syndicate accounts for additional outreach

Post-IPO

• Created plan of action immediately following IPO to plan for follow on offering
• Arranged 2 non-deal roadshows in the U.S. and Europe
• Added additional investor meetings surrounding 5 investor conferences in the U.S. and Europe
• Organized 3 full days of investor meetings surrounding the J.P. Morgan Healthcare Conference
• Frequent weekly calls with potential investors

 Results

• Company raised $41 million in over-subscribed IPO
• Met with top-tier HC buy-side firms resulting in 250,000 share purchase in IPO for $2.5 million investment
• Investment represented 6% of IPO proceeds
• Targeted investors participated in follow on offering or made subsequent open market investments in company
• Successful July 2015 follow-on offering raising $67 million including a 20% upsize